Cargando…
Entrepreneurialism in the Translational Biologic Sciences: Why, How, and However
Because they are perceived as distinct from the biological sciences, entrepreneurial pursuits may be daunting to the average researcher. In this report, we explain why academic scientists and in particular translational researchers should be naturally as well as rationally attracted to entrepreneuri...
Autores principales: | Bristow, Michael R., Leinwand, Leslie A., Olson, Eric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058957/ https://www.ncbi.nlm.nih.gov/pubmed/30062188 http://dx.doi.org/10.1016/j.jacbts.2017.10.004 |
Ejemplares similares
-
How to Start a Biomedical Device Company: Physicians Can Lead the Team Effort
por: DiMaio, J. Michael, et al.
Publicado: (2017) -
Update to Drugs, Devices, and the FDA: How Recent Legislative Changes Have Impacted Approval of New Therapies
por: Van Norman, Gail A.
Publicado: (2020) -
Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”
por: Van Norman, Gail A.
Publicado: (2018) -
Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
por: Van Norman, Gail A.
Publicado: (2018) -
Expanded Patient Access to Investigational New Devices: Review of Emergency and Nonemergency Expanded Use, Custom, and 3D-Printed Devices
por: Van Norman, Gail A.
Publicado: (2018)